Skip to main content
Tech.euFundingExplorerBeta

Salvia BioElectronics

We believe that people with migraine deserve to reclaim their life. Salvia BioElectronics is pioneering neuromodulation therapy aiming to transform the migraine treatment landscape.

Total raised
€53M
€52,712,405
Funding rounds
1
Investors
9
distinct backers
Active since
2025-05
latest 2025-05

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood53
base rate 48% for Series B
  • In typical raise window
  • Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 rounds

Related news

Similar companies

same sector or country